Similarly, the CardShock study measured IL-6 levels in 183 patients with CS (AMI-CS was the specific etiology in 79% of the patients), showing that patients with IL-6 levels above the median had more often signs of hypoperfusion and higher 90-day mortality rates [33]. Here, IL6 is linked to Cowden syndrome 1.